These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 35034116

  • 1. Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV, Guyonnet S, Morley JE, Nguyen AD, Aggarwal G, Parini A, Li Y, Bateman RJ, Vellas B, de Souto Barreto P, MAPT/DSA Group.
    J Gerontol A Biol Sci Med Sci; 2022 Jun 01; 77(6):1159-1168. PubMed ID: 35034116
    [Abstract] [Full Text] [Related]

  • 2. TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study.
    Giudici KV, de Souto Barreto P, Guyonnet S, Morley JE, Nguyen AD, Aggarwal G, Parini A, Li Y, Bateman RJ, Vellas B, MAPT/DSA Group.
    J Gerontol A Biol Sci Med Sci; 2023 Mar 30; 78(4):569-578. PubMed ID: 36508390
    [Abstract] [Full Text] [Related]

  • 3. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.
    Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P, MAPT/DSA Group.
    Alzheimers Res Ther; 2022 Jan 07; 14(1):5. PubMed ID: 34996522
    [No Abstract] [Full Text] [Related]

  • 4. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults.
    He L, de Souto Barreto P, Aggarwal G, Nguyen AD, Morley JE, Li Y, Bateman RJ, Vellas B, MAPT/DSA Group.
    Alzheimers Res Ther; 2020 Oct 08; 12(1):128. PubMed ID: 33032662
    [Abstract] [Full Text] [Related]

  • 5. Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults.
    He L, Morley JE, Aggarwal G, Nguyen AD, Vellas B, de Souto Barreto P, MAPT/DSA Group.
    Sci Rep; 2021 Jun 28; 11(1):13394. PubMed ID: 34183688
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV, de Souto Barreto P, Guyonnet S, Li Y, Bateman RJ, Vellas B, MAPT/DSA Group.
    JAMA Netw Open; 2020 Dec 01; 3(12):e2028634. PubMed ID: 33331917
    [Abstract] [Full Text] [Related]

  • 7. Cross-Sectional and Longitudinal Associations Between Plasma Neurodegenerative Biomarkers and Physical Performance Among Community-Dwelling Older Adults.
    He L, de Souto Barreto P, Giudici KV, Aggarwal G, Nguyen AD, Morley JE, Li Y, Bateman RJ, Vellas B, MAPT/DSA Group.
    J Gerontol A Biol Sci Med Sci; 2021 Sep 13; 76(10):1874-1881. PubMed ID: 33186456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort.
    Grasset L, Bouteloup V, Cacciamani F, Pellegrin I, Planche V, Chêne G, Dufouil C, MEMENTO study groupFrom the UMR 1219 (L.G., V.B., F.C., G.C., C.D.), Bordeaux Population Health Center, University of Bordeaux, Inserm; CIC 1401-EC (L.G., V.B., F.C., G.C., C.D.), Inserm, University of Bordeaux, CHU de Bordeaux; Centre Hospitalier Universitaire (CHU) de Bordeaux (V.B., G.C., C.D.), Pole de sante publique; ARAMISLab (F.C.), Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière; Qairnel SAS (F.C.), Paris; Laboratory of Immunology and Immunogenetics (I.P.), Resources Biological Center (CRB), CHU Bordeaux; Univ. Bordeaux (I.P.), CNRS, ImmunoConcEpT, UMR 5164; and Univ. Bordeaux (V.P.), CNRS UMR 5293, Institut des Maladies Neurodégénératives, Centre Mémoire de Ressources et de Recherches, Pôle de Neurosciences Cliniques, CHU de Bordeaux, France..
    Neurology; 2024 May 13; 102(9):e209307. PubMed ID: 38626384
    [Abstract] [Full Text] [Related]

  • 10. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial.
    Coley N, Zetterberg H, Cantet C, Guyonnet S, Ashton NJ, Vellas B, Blennow K, Andrieu S, MAPT study group.
    Lancet Healthy Longev; 2024 Feb 13; 5(2):e120-e130. PubMed ID: 38310892
    [Abstract] [Full Text] [Related]

  • 11. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
    Chen CY, Chiu CC, Huang CY, Cheng YC, Huang MC, Kuo PH, Chen WY.
    BMC Geriatr; 2024 Apr 16; 24(1):344. PubMed ID: 38627748
    [Abstract] [Full Text] [Related]

  • 12. Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults.
    Lu WH, Giudici KV, Morley JE, Guyonnet S, Parini A, Aggarwal G, Nguyen AD, Li Y, Bateman RJ, Vellas B, de Souto Barreto P, MAPT/DSA Group.
    Geroscience; 2022 Jun 16; 44(3):1489-1503. PubMed ID: 35445358
    [Abstract] [Full Text] [Related]

  • 13. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V, MAPT/DSA study group.
    Br J Clin Pharmacol; 2019 Jan 16; 85(1):71-99. PubMed ID: 30098049
    [Abstract] [Full Text] [Related]

  • 14. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJ, AV45-A11 Study Group.
    Neurology; 2012 Oct 16; 79(16):1636-44. PubMed ID: 22786606
    [Abstract] [Full Text] [Related]

  • 15. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K.
    JAMA Neurol; 2019 Mar 01; 76(3):318-325. PubMed ID: 30508027
    [Abstract] [Full Text] [Related]

  • 16. Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT Study.
    Raffin J, Rolland Y, Aggarwal G, Nguyen AD, Morley JE, Li Y, Bateman RJ, Vellas B, Barreto PS, MAPT/DSA Group.
    J Gerontol A Biol Sci Med Sci; 2021 Jul 13; 76(8):1382-1390. PubMed ID: 33864068
    [Abstract] [Full Text] [Related]

  • 17. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B, MAPT Study Group.
    Lancet Neurol; 2017 May 13; 16(5):377-389. PubMed ID: 28359749
    [Abstract] [Full Text] [Related]

  • 18. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
    Huang Y, Li Y, Xie F, Guo Q.
    CNS Neurosci Ther; 2022 Dec 13; 28(12):2195-2205. PubMed ID: 36074638
    [Abstract] [Full Text] [Related]

  • 19. Periostin Plasma Levels and Changes on Physical and Cognitive Capacities in Community-Dwelling Older Adults.
    Sánchez-Sánchez JL, Ader I, Jeanson Y, Planat-Benard V, Vellas B, Casteilla L, de Souto-Barreto P.
    J Gerontol A Biol Sci Med Sci; 2023 Mar 01; 78(3):424-432. PubMed ID: 36373873
    [Abstract] [Full Text] [Related]

  • 20. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F, Ghanbari M, Licher S, McRae-McKee K, Gras L, Weverling GJ, Wermeling P, Sedaghat S, Ikram MK, Waziry R, Koudstaal W, Klap J, Kostense S, Hofman A, Anderson R, Goudsmit J, Ikram MA.
    Brain; 2020 Apr 01; 143(4):1220-1232. PubMed ID: 32206776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.